140 related articles for article (PubMed ID: 8595170)
21. Incidence of contralateral-bilateral nodes in the human papillomavirus era.
Tritter AG; Mehta V; Samuelson M; deGravelle G; Ma X; Medlin-Moore T; Takalkar A; Caldito G; Nathan CO
Laryngoscope; 2017 Jun; 127(6):1328-1333. PubMed ID: 27905120
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
[TBL] [Abstract][Full Text] [Related]
23. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
[TBL] [Abstract][Full Text] [Related]
24. Infiltrating CD57+ inflammatory cells in head and neck squamous cell carcinoma: clinicopathological analysis and prognostic significance.
Fraga CA; de Oliveira MV; Domingos PL; Botelho AC; Guimarães AL; Teixeira-Carvalho A; Correa-Oliveira R; De Paula AM
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):285-90. PubMed ID: 22505010
[TBL] [Abstract][Full Text] [Related]
25. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
[TBL] [Abstract][Full Text] [Related]
26. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
[TBL] [Abstract][Full Text] [Related]
27. Lymphnode metastasis in head and neck squamous cells carcinoma: multivariate analysis of prognostic variables.
Magnano M; Bongioannini G; Lerda W; Canale G; Tondolo E; Bona M; Viora L; Gabini A; Gabriele P
J Exp Clin Cancer Res; 1999 Mar; 18(1):79-83. PubMed ID: 10374683
[TBL] [Abstract][Full Text] [Related]
28. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
29. A novel classification system for perineural invasion in noncutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes.
Miller ME; Palla B; Chen Q; Elashoff DA; Abemayor E; St John MA; Lai CK
Am J Otolaryngol; 2012; 33(2):212-5. PubMed ID: 22177613
[TBL] [Abstract][Full Text] [Related]
30. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
32. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
[TBL] [Abstract][Full Text] [Related]
33. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
34. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival.
Cooke LD; Cooke TG; Forster G; Jones AS; Stell PM
Br J Cancer; 1994 Apr; 69(4):717-20. PubMed ID: 8142259
[TBL] [Abstract][Full Text] [Related]
36. Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection.
Inokuchi H; Kodaira T; Tachibana H; Nakamura T; Tomita N; Nakahara R; Takada A; Mizoguchi N; Tamaki T; Fuwa N
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):747-55. PubMed ID: 20434274
[TBL] [Abstract][Full Text] [Related]
37. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chang CL; Yuan KS; Wu SY
Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma.
Querellou S; Abgral R; Le Roux PY; Nowak E; Valette G; Potard G; Le Duc-Pennec A; Cavarec MB; Marianovski R; Salaün PY
Head Neck; 2012 Apr; 34(4):462-8. PubMed ID: 21604320
[TBL] [Abstract][Full Text] [Related]
39. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
40. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.
Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M
J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]